Resolute efforts to cure hepatitis C: Understanding patients’ reasons for completing antiviral treatment

Health (United Kingdom)

Volumn 19, Issue 5, 2015, Pages 473-489

  Clark, Jack A ^a,b   Gifford, Allen L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

ethnography; health policy; illness behavior

Indexed keywords

ANTIVIRUS AGENT;

AGED; CULTURAL ANTHROPOLOGY; FEMALE; GOVERNMENT; HEALTH CARE POLICY; HEPATITIS C; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; SOCIAL STIGMA; UNITED STATES;

AGED; ANTHROPOLOGY, CULTURAL; ANTIVIRAL AGENTS; FEMALE; HEALTH POLICY; HEPATITIS C; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SOCIAL STIGMA; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84940920760     PISSN: 13634593     EISSN: 14617196     Source Type: Journal    
DOI: 10.1177/1363459314555237     Document Type: Article

References (45)

1. M.BeachJ.KerulyR.Moore (2006) Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?Journal of General Internal Medicine21: 661–665.
2. L.BesteG.IoannouM.Larson. (2010) Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication. Clinical Gastroenterology and Hepatology8: 972–978.
3. J.BonnerA.BarrittM.Fried. (2012) Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues. Digestive Diseases and Sciences57: 1469–1474.
4. A.ButtM.WagenerA.Shakil. (2005) Reasons for non-treatment of hepatitis C in veterans in care. Journal of Viral Hepatitis12: 81–85.
5. E.S.Carr (2011) Scripting Addiction: The Politics of Therapeutic Talk and American Sobriety. Princeton, NJ: Princeton University Press.
6. J.ClarkE.Mishler (1992) Attending to patients’ stories: Reframing the clinical task. Sociology of Health & Illness14: 344–372.
7. L.CoxheadT.Rhodes (2006) Accounting for risk and responsibility associated with smoking among mothers with respiratory illness. Sociology of Health & Illness28: 98–121.
8. Department of Veterans Affairs (DVA) (2010) The State of Care for Veterans with Chronic Hepatitis C. Washington, DC: Center for Quality Management in Public Health, Public Health Strategic Health Care Group.
9. J.DominitzE.BoykoT.Koepsell.; VA Cooperative Study Group 488 (2005) Elevated prevalence of HCV infection in users of US veterans medical centers. Hepatology41: 88–96.
10. J.Duffin (2005) Lovers and Livers: Disease Concepts in History. Toronto, ON, Canada: University of Toronto Press.
11. D.EvonK.SimpsonX.Kixmiller. (2011) A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment. American Journal of Gastroenterology106: 1777–1786.
12. L.FraenkelD.ChodkowskiJ.Lim. (2010) Patients’ preferences for treatment of hepatitis C. Medical Decision Making30: 45–57.
13. L.FraenkelS.McGrawS.Wongcharatrawee. (2005) What do patients consider when making decisions about treatment for hepatitis C?American Journal of Medicine118: 1387–1391.
14. S.Fraser (2010a) Hepatitis C and the limits of medicalization and biological citizenship for people who inject drugs. Addiction Research & Theory18: 544–556.
15. S.Fraser (2010b) More than one and less than many: Materializing hepatitis C and injecting drug use in self-help literature and beyond. Health Sociology Review19: 230–244.
16. L.FusfeldJ.AggarwalC.Dougher. (2013) Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection. BMC Infectious Diseases13: 234.
17. M.GhanyD.NelsonD.Strader. (2011) An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guidelines by the American Association for the Study of Liver Diseases. Hepatology54: 1433–1444.
18. M.HarrisT.RhodesA.Martin (2013) Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting. Social Science & Medicine83: 19–26.
19. M.HopwoodC.Treloar (2005) The experience of interferon-based treatments for hepatitis C infection. Qualitative Health Research15: 635–646.
20. S.HoE.GroesslA.Dollarhide. (2008) Management of chronic hepatitis C in veterans: The potential of integrated care models. American Journal of Gastroenterology103: 1810–1823.
21. Institute of Medicine (2010) Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: The National Academies Press.
22. A.JennerA.Scott (2008) Circulating beliefs, resilient metaphors and faith in biomedicine: Hepatitis C patients and interferon combination therapy. Sociology of Health & Illness30: 197–216.
23. A.KnottE.DieperinkM.Willenbring. (2006) Integrated psychiatric/medical care in a chronic hepatitis C clinic: Effect on antiviral treatment evaluation and outcomes. American Journal of Gastroenterology101: 2254–2262.
24. J.KramerF.KanwalP.Richardson. (2012) Gaps in the achievement of effectiveness of HCV treatment in national VA practice. Journal of Hepatology56: 320–325.
25. M.LeeH.YangS.Lu. (2012) Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study. Journal of Infectious Diseases206: 469–477.
26. V.Lo ReV.TealR.Localio. (2012) Relationship between adherence to hepatitis C virus therapy and virologica outcomes: A cohort study. Annals of Internal Medicine155: 353–360.
27. L.McCoy (2005) HIV-positive patients and the doctor-patient relationship: Perspectives from the margins. Qualitative Health Research15: 791–806.
28. C.McGowanM.Fried (2012) Barriers to hepatitis C treatment. Liver International32: 151–156.
29. A.MalpassA.ShawD.Sharp. (2009) “Medication career” or “moral career”? The two sides of managing antidepressants: A meta-ethnography of patients’ experience of antidepressants. Social Science & Medicine68: 154–168.
30. M.ManosC.HoR.Murphy. (2013) Physical, social, and psychological consequences of treatment for hepatitis C. The Patient6: 23–34.
31. E.Mishler (1991) Research Interviewing: Context and Narrative. Cambridge, MA: Harvard University Press.
32. E.Mykhalovskiy (2008) Beyond decision making: Class, community organizations, and the healthwork of people living with HIV/AIDS. Contributions from institutional ethnographic research. Medical Anthropology27: 136–163.
33. M.OrsiniF.Scala (2006) “Every virus tells a story”: Toward a narrative-centered approach to health policy. Policy and Society25: 109–130.
34. K.OsillaG.RyanL.Bhatti. (2009) Factors that influence an HIV coinfected patient’s decision to start hepatitis C treatment. AIDS Patient Care and STDs23: 993–999.
35. B.PatersonM.BackmundG.Hirsch. (2007) The depiction of stigmatization in research about hepatitis C. International Journal of Drug Policy18: 364–373.
36. F.PollettaP.ChingP.Chen. (2011) The sociology of storytelling. Annual Review of Sociology37: 109–130.
37. T.RhodesM.HarrisA.Martin (2013) Negotiating access to medical treatment and the making of patient citizenship: The case of hepatitis C treatment. Sociology of Health & Illness35: 1023–1044.
38. C.Riessman (1993) Narrative Analysis. Newbury Park, CA: SAGE.
39. R.RyanR.PlantS.O’Malley (1995) Initial motivations for alcohol treatment: Relations with patient characteristics, treatment involvement, and dropout. Addictive Behaviors20: 279–297.
40. A.TalalJ.LaFleurR.Hoop. (2013) Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: Results from a US database of over 45000 HCV infected, evaluated patients. Alimentary Pharmacology & Therapeutics37: 473–481.
41. C.TreloarM.Hopwood (2009) The lived experience of hepatitis C and its treatment among injecting drug users: Qualitative synthesis. Qualitative Health Research19: 1321–1334.
42. G.Williams (1993) Chronic illness and the pursuit of virtue in everyday life. In: A.Radley (ed.) World of Illness: Biographical and Cultural Perspectives on Health and Disease. London: Routledge, pp. 92–108.
43. S.ZacksK.BeaversD.Theodore. (2006) Social stigmatization and hepatitis C infection. Journal of Clinical Gastroenterology40: 220–224.
44. S.ZickmundS.HillisM.Barnett. (2004) Hepatitis C virus-infected patients report communication problems with physicians. Hepatology39: 999–1007.
45. S.ZickmundE.HoM.Masuda. (2003) “They treated me like a leper” stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine18: 835–844.